NCT06414122

Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients

Name: Clinical Trial NCT06414122
Creator: University of Cologne
Keywords: Oesophageal Cancer,Gastric Cancer,Duodenal Cancer,Colorectal Cancer, mid-frequency whole-body electromyostimulation (WB-EMS), other, clinical trial, Germany

The Efficacy of Modulated Mid-frequency (Whole-body Electromyostimulation) and Nutritional Therapy in Patients With Solid Tumors of the Gastrointestinal Tract (Excluding Liver and Pancreatic Carcinomas)

University of Cologne·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Oesophageal Cancer,Gastric Cancer,Duodenal Cancer,Colorectal Cancer
Drug/Device/Intervention: mid-frequency whole-body electromyostimulation (WB-EMS)
Study type: Interventional
Intervention type: other

Sponsor & location

Primary sponsor: University of Cologne
Location: Cologne, Germany

Timeline & enrollment

Phase: N/A
Start date: Jul 01, 2024
End date: Sep 01, 2026
Enrollment: 88 participants

Primary outcome

Muscle mass of the quadriceps muscle

Summary

The purpose of this study is to assess the efficacy of modulated mid-frequency whole-body electromyostimulation (WB-EMS) combined with nutritional therapy in patients with gastrointestinal cancer.

ICD-10 classifications

Diseases of oesophagus, stomach and duodenumCarcinoma in situ: OesophagusMalignant neoplasm: Abdominal part of oesophagusMalignant neoplasm: Middle third of oesophagusMalignant neoplasm: Overlapping lesion of oesophagus

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06414122
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06414122 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Cologne and is currently Not yet recruiting. The study focuses on Oesophageal Cancer,Gastric Cancer,Duodenal Cancer,Colorectal Cancer. Target enrollment is 88 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.